-53%

est. 2Y upside i

HealthcareSeries B

Quality-first data labeling for model evaluation and training

Rank

#744

Sector

Healthcare AI Data Annotation

Est. Liquidity

~4Y

Data Quality

Data: Medium

Centaur.ai presents a strong upside opportunity driven by its specialized position in the rapidly expanding healthcare AI data annotation market.

Last updated: March 10, 2026

Bull (30%)+250%

Centaur.ai's specialized expertise, HIPAA-compliant platform, and new on-demand data labeling product drive significant market penetration in healthcare AI. Expansion into synthetic financial data also gains traction, pushing annual revenue to over $100M by 2027 and justifying a $245M+ valuation, a 3.5x increase from current levels.

Base (50%)+75%

Centaur.ai maintains its strong position in the core healthcare data annotation market, growing revenue to approximately $50M by 2027 through expanding existing customer relationships and moderate new client acquisition. This leads to an exit valuation of around $122.5M, reflecting steady growth and market capture.

Bear (20%)-60%

Increased competition from generalist AI platforms and large healthcare incumbents erodes Centaur.ai's market share, and regulatory hurdles slow expansion into new segments. Revenue growth stalls, leading to a down round or acquisition at a $28M valuation, significantly impacting common stock value due to substantial liquidation preferences.

Est. time to liquidity~3.5 years

Preference Stack Risk

severe

Funding Intensity

45%

Investors hold $32M in liquidation preferences ahead of common stock, meaning in an exit at or below the current $70M valuation, common shareholders may receive little to nothing.

Dilution Risk

high

As a Series B company, Centaur.ai will likely require additional funding rounds to scale, leading to further dilution for common shareholders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for Centaur.ai equity at this stage.

View all 2 open roles at Centaur →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Centaur's data — designed to show you've done your homework.

  • 1

    “How is Centaur.ai planning to scale its global network of medical experts to meet the projected demand in the rapidly growing healthcare AI data annotation market, while maintaining your high-quality standards and competitive moat?”

  • 2

    “With the launch of your on-demand data labeling platform and exploration into synthetic financial data, how do these new initiatives align with your core healthcare strategy and what are the key metrics you're tracking for their success?”

  • 3

    “Given the Series B funding and the significant liquidation preferences, what is the company's anticipated timeline and strategy for a liquidity event that would provide meaningful returns for common shareholders, and how do you communicate this to employees?”

Community

Valuation Sentiment

Our model estimates -53% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.